22 May 2013
Keywords: mylan, sees, drop, fourth-qtr, profit, generics, drugmaker
Article | 23 May 2005
Generics drugmaker Mylan says that net revenues for the fiscal year to March 31, 2005, were $1.25 billion, down 9% on the previous 12 months, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.